Global Active Pharmaceutical Ingredients Market (2021-2026) – Industry Trends, Share, Size, Growth, Opportunity, and Forecast

DUBLIN, June 1, 2021 The report “Active Pharmaceutical Ingredients (API) Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2021-2026″ has been added to ResearchAndMarkets.com from offer.

The global active pharmaceutical ingredients (API) market has reached a value of US $ 200.6 billion in 2020. Active Pharmaceutical Ingredient (API) is the term used to refer to the biologically active component of a drug (eg, tablet, capsule). A medicine is usually made up of several components. The API is the main ingredient. Other ingredients are commonly referred to as “excipients”. Sometimes a medicine may contain more than one API and its effect on a patient depends on the prescribed dosage and may vary from person to person. In combination therapies, two or more active ingredients are used to treat different symptoms in different ways. Stringent quality control is a mandate when it comes to drug manufacturing, as API is the main component taken into account when prescribing.

Pharmaceutical manufacturing takes place in two general stages. In the first step, manufacturers convert raw materials into APIs. The second step is to create the final formulation by mixing APIs and excipients into tablets, capsules, solutions, etc. and finally to package the drug for end users. Manufacturers sell APIs on the open market (also known as the merchant market) or use them as inputs to make their final formulations. The global API market is extremely competitive with a number of large and small manufacturers. Companies that are embarking on API manufacturing specialize and typically target their manufacturing based on a combination of the company’s internal skills and market opportunities. Catalyzed by falling costs, API manufacturing has gradually shifted from historical leaders in Western countries to manufacturers based in India and China.

The worldwide demand for APIs is currently growing strongly. One of the main drivers of this market is the increasing number of successful patent expirations, creating a significant opportunity for generic APIs. In addition, there has been a strong demand for APIs for biologics. The global biologics market is currently showing strong growth catalyzed by their high potency and ability to treat diseases beyond the scope of small molecule drugs. This is creating a strong API demand for brand name biologics and their biosimilar versions. Other factors catalyzing the global demand for APIs include an aging population, increasing healthcare spending, increasing prevalence of lifestyle-related diseases, and more. Looking ahead, the publisher expects the global active pharmaceutical ingredients (APIs) market to show moderate growth during the forecast period (2021-2026).

Competitive landscape:

The competitive landscape of the market was also examined with some of the major players (active pharmaceutical ingredient companies) being Pfizer, Inc., Novartis International AG, Sanofi, Boehringer Ingelheim, Bristol-Myers Squibb, Teva Pharmaceutical Industries Ltd., ELI Lilly and company, GlaxoSmithKline, Merck & Co., Inc. and Abbvie Inc.

Key questions addressed in this report:

  • How has the global active pharmaceutical ingredients (API) market performed so far and how will it perform in the years to come?
  • What has been the impact of COVID-19 on the global active pharmaceutical ingredients (API) industry?
  • What are the key regional markets for the global active pharmaceutical ingredients (API) industry?
  • What is the global active pharmaceutical ingredients (API) market split based on drug type?
  • What is the global active pharmaceutical ingredients (API) market split based on type of manufacturer?
  • How is the global active pharmaceutical ingredients (API) market split on the basis of synthesis?
  • How is the global active pharmaceutical ingredients (API) market split on the basis of therapeutic application?
  • What are the different stages in the global active pharmaceutical ingredients (API) market value chain?
  • What are the major drivers and challenges in the global active pharmaceutical ingredients (APIs) market?
  • What is the structure of the global active pharmaceutical ingredients (API) market and who are the major players?
  • How competitive is the global active pharmaceutical ingredients (API) market?
  • How are active pharmaceutical ingredients (APIs) made?

Main topics covered:

1 Preface

2 Scope and methodology

3 Executive summary

4 Presentation
4.1 Overview
4.2 Key Industry Trends

5 Global Active Pharmaceutical Ingredient (API) Market
5.1 Market overview
5.2 Market performance
5.3 Impact of COVID-19
5.4 Market breakdown by type of drug
5.5 Market breakdown by type of manufacturer
5.6 Market breakdown by type of synthesis
5.7 Market breakdown by therapeutic application
5.8 Market breakdown by region
5.9 Market Forecast
5.10 SWOT analysis
5.11 Value chain analysis
5.12 Porters Five Forces Analysis
5.13 Price analysis

6 Market breakdown by type of drug
6.1 Innovative Active Pharmaceutical Ingredients (APIs)
6.2 Generic Active Pharmaceutical Ingredients (APIs)

7 Market breakdown by type of manufacturer
7.1 Captive manufacturers
7.2 Merchant API manufacturers
7.2.1 Innovative Merchant API Manufacturers
7.2.2 Generic Merchant API Manufacturers

8 Market breakdown by type of synthesis
8.1 Synthetic Active Pharmaceutical Ingredients (APIs)
8.1.1 Market breakdown by type
8.1.1.1 Innovative synthetic APIs
8.1.1.2 Generic synthetic APIs
8.2 Biotech Active Pharmaceutical Ingredients (APIs)
8.2.1 Market breakdown by type
8.2.1.1 Innovative biotechnological APIs
8.2.1.2 Biosimilars
8.2.2 Market breakdown by product
8.2.2.1 Monoclonal antibodies
8.2.2.2 Vaccines
8.2.2.3 Cytokines
8.2.2.4 Fusion proteins
8.2.2.5 Therapeutic enzymes
8.2.2.6 Blood factors
8.2.3 Market breakdown by expression system
8.2.3.1 Mammalian expression systems
8.2.3.2 Microbial expression systems
8.2.3.3 Yeast expression systems
8.2.3.4 Transgenic animal systems
8.2.3.5 Others

9 Market breakdown by therapeutic application
9.1 Oncology
9.2 Cardiovascular and respiratory
9.3 Diabetes
9.4 Central nervous system disorders
9.5 Neurological disorders
9.6 Others

10 Market breakdown by region
10.1 North America
10.1.1 United States
10.1.2 Canada
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 UK
10.2.4 Italy
10.2.5 Spain
10.2.6 Russia
10.2.7 Others
10.3 Asia Pacific
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Australia
10.3.6 Indonesia
10.3.7 Others
10.4 Latin America
10.5 Middle East and Africa

11 API manufacturing process
11.1 Product overview
11.2 Raw material requirements
11.3 Manufacturing process
11.4 Main success and risk factors

12 Competitive landscape
12.1 Market structure
12.2 Key players
12.3 Profiles of key players

For more information on this report, visit https://www.researchandmarkets.com/r/bla9v3

Media contact:

Research and markets
Laura Wood, Main director
[email protected]

For EST office hours, call + 1-917-300-0470
For USA / CAN toll free + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900

US Fax: 646-607-1907
Fax (outside the United States): + 353-1-481-1716

Cision View original content: http://www.prnewswire.com/news-releases/global-active-pharmaceutical-ingredients-market-2021-to-2026—industry-trends-share-size-growth-opportunity-and – forecast-301303164.html

SOURCE Research and Markets


Source link

About Margie Peters

Check Also

Gujarat: Indian Company’s Tablet PCs Fail Quality Test, NAMO Program Delayed Again

The Gujarat government’s plan to provide NAMO tablet computers to undergraduates was further delayed after …

Leave a Reply

Your email address will not be published. Required fields are marked *